{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-26-001302","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2026-08-10T21:00:22+00:00","discovered_at":"2026-08-10T21:02:04.019592+00:00","generated_at":"2026-08-10T21:02:16.460109+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Lexaria Bioscience receives Nasdaq delisting notice but expects compliance via reverse split","bullets":["Received Nasdaq delisting notice Aug 4, 2026 for failing to regain $1 minimum bid price within 180-day period.","Completed reverse stock split Aug 3, 2026 (announced Jul 30); shares now trading above $1 under CUSIP 52886N604.","Filed hearing request and paid fee to stay delisting; expects to regain compliance before hearing date.","Company expects shares to continue trading on Nasdaq without interruption."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-26-001302","json":"https://secwatch.observer/filing/0001640334-26-001302.json","markdown":"https://secwatch.observer/filing/0001640334-26-001302.md","text":"https://secwatch.observer/filing/0001640334-26-001302.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033426001302/0001640334-26-001302-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033426001302/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T21:02:16.460109+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}